Sagent Pharmaceuticals, Inc.·4

Feb 19, 9:15 PM ET

Sagent Pharmaceuticals, Inc. 4

4 · Sagent Pharmaceuticals, Inc. · Filed Feb 19, 2014

Insider Transaction Report

Form 4
Period: 2014-02-18
Transactions
  • Award

    Stock Option to Buy

    2014-02-18+11,96811,968 total
    Exercise: $20.16Exp: 2024-02-18Common Stock (11,968 underlying)
  • Award

    Common Stock

    2014-02-18+6,6966,696 total
Footnotes (1)
  • [F1]The option vests in four equal installments beginning on February 18, 2015.

Documents

1 file
  • 4
    rrd402822.xmlPrimary